Regulatory Procedure Management (RPM) for the Product Lifecycle Management (PLM) - Frequently asked questions
Regulatory Procedure Management (RPM) for the Product Lifecycle Management (PLM) - Frequently asked questions
Regulatory Procedure Management (RPM) for the Product Lifecycle Management (PLM) - Frequently asked questions
Human medicines European public assessment report (EPAR): Spherox, spheroids of human autologous matrix-associated chondrocytes, Date of authorisation: 10/07/2017, Revision: 9, Status: Authorised
Human medicines European public assessment report (EPAR): Modigraf, tacrolimus, Date of authorisation: 15/05/2009, Revision: 21, Status: Authorised
Clinical Trials Information System (CTIS) bitesize talk: End of transition period and notifications including serious breach, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 16 October 2024, 15:30 (CEST) to 16 October 2024, 17:00 (CEST)
Clinical Trials Information System (CTIS) Bitesize Talk: Revised transparency rules and the new CTIS public portal, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 20 June 2024, 15:30 (CEST) to 20 June 2024, 17:00 (CEST)
Human medicines European public assessment report (EPAR): Torisel, temsirolimus, Date of authorisation: 19/11/2007, Revision: 35, Status: Authorised
Withdrawn application: Bimervax, 05/02/2025
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 24-27 February 2025
Summary of opinion: Abrysvo, 27/02/2025 Positive
Summary of opinion: Calquence, 27/02/2025 Positive